Patent Assignment
Reel/Frame 008760/0096
Assignment of Assignor's Interest
Recorded: 1997-10-20
Pages: 3
Assignor
UNIVERSITY OF ALBERTA, THE
Executed: 1997-10-03
Assignee
JOHN P. ROBARTS INSTITUTE, THE
100 PERTH DRIVE, LONDON, ONTARIO, N6A 5, CANADA
Covered Property
(1)
Chemokine Binding Protein and Methods of Use Therefor
Patent:
5,834,419 →
Application:
08/634,924 →
Related Assignments
(10)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 29, 1996
From: MCFADDEN, GRANT; LUCAS, ALEXANDRA
To: UNIVERSITY OF ALBERTA, THE
Reel/Frame 008049/0936 →
Security Interest
Dec 8, 2003
From: VIRON THERAPEUTICS INC.
To: EASTERN TECHNOLOGY SEED INVESTMENT FUND LIMITED PARTNERSHIP; TRUDELL MEDICAL LIMITED; NOVARTIS PHARMA AG (AS ASSIGNEE OF NOVARTIS INTERNATIONAL AG); ROYAL BANK OF CANADA
Reel/Frame 014754/0290 →
Security Interest
Dec 9, 2003
From: VIRON THERAPEUTICS INC.
To: TRUDELL MEDICAL LIMITED; NOVARTIS PHARMA AG
Reel/Frame 014754/0221 →
Security Interest
Dec 9, 2003
From: VIRON THERAPEUTICS INC.
To: TRUDELL MEDICAL LIMITED; NOVARTIS PHARMA AG (AS ASSIGNEE OF NOVARTIS INTERNATIONAL AG); ROYAL BANK OF CANADA; GENECHEM TECHNOLOGIES VENTURE FUND, L.P.
Reel/Frame 014754/0266 →
Security Agreement
Jul 12, 2004
From: VIRON THERAPEUTICS INC.
To: TRUDELL MEDICAL LIMITED; NOVARTIS PHARMA AG
Reel/Frame 016256/0117 →
Assignment of Assignor's Interest
Dec 8, 2004
From: JOHN P. ROBARTS RESEARCH INSTITUE, THE
To: VIRON THERAPEUTICS, INC.
Reel/Frame 016046/0558 →
Security Agreement
Jul 8, 2008
From: EASTERN TECHNOLOGY SEED INVESTMENT FUND LIMITED PARTNERSHIP; TRUDELL MEDICAL LIMITED; NOVARTIS PHARMA AG; ROYAL BANK OF CANADAD
To: VIRON THERAPEUTICS INC.
Reel/Frame 021205/0109 →
Security Agreement
Jul 8, 2008
From: TRUDELL MEDICAL LIMITED; NOVARTIS PHARMA AG
To: VIRON THERAPEUTICS INC.
Reel/Frame 021205/0143 →
Security Agreement
Jul 8, 2008
From: TRUDELL MEDICAL LIMITED; NOVARTIS PHARMA AG
To: VIRON THERAPEUTICS INC.
Reel/Frame 021205/0135 →
Security Agreement
Jul 8, 2008
From: TRUDELL MEDICAL LIMITED; NOVARTIS PHARMA AG; ROYAL BANK OF CANADAD; GENECHEM TECHNOLOGIES VENTURE FUND, L.P.
To: VIRON THERAPEUTICS INC.
Reel/Frame 021205/0124 →